Triple Semicircular Canal Occlusion + Endolymphatic Sac Decompression Alleviates Vertigo
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 5, 2024 -- Triple semicircular canal occlusion combined with endolymphatic sac decompression (ESD) may be an effective treatment option for managing frequent vertigo attacks in patients with Meniere disease, according to a study published online April 16 in Frontiers in Neurology.
Jiawang Tian, from the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou, China, and colleagues evaluated the efficacy of triple semicircular canal occlusion combined with endolymphatic sac decompression in the treatment of frequent vertigo in patients with Meniere disease. The analysis included 11 patients enrolled to undergo triple semicircular canal occlusion with endolymphatic sac decompression.
The researchers found that the successful control rate of vertigo was 100 percent (nine of nine) in the average 23-month postoperative follow-up period, with a complete control rate of 88.89 percent (eight of nine) and substantial control rate of 11.11 percent (one of nine).
"Triple semicircular canal occlusion combined with endolymphatic sac decompression may be an effective treatment option for managing frequent vertigo attacks in patients with Meniere disease," the authors write. "This combination therapy has the potential to become a significant addition to the treatment framework for Meniere disease."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures
WEDNESDAY, June 26, 2024 -- Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a...
Cochlear Implants Aid Meniere Disease Outcomes
TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...
No Causal Association Seen for Meniere Disease, Migraine
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.